Tan TM - Search Results

1

Glucagon-based therapy for people with diabetes and obesity: What is the sweet spot?

McGlone ER, Tan TM. McGlone ER, et al. Among authors: tan tm. Peptides. 2024 Jun;176:171219. doi: 10.1016/j.peptides.2024.171219. Epub 2024 Apr 13. Peptides. 2024. PMID: 38615717 Free article. Review.

2

RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and Signaling.

Cegla J, Jones BJ, Gardiner JV, Hodson DJ, Marjot T, McGlone ER, Tan TM, Bloom SR. Cegla J, et al. Among authors: tan tm. Endocrinology. 2017 Aug 1;158(8):2680-2693. doi: 10.1210/en.2016-1755. Endocrinology. 2017. PMID: 28586439 Free PMC article.

3

Oxyntomodulin analogue increases energy expenditure via the glucagon receptor.

Scott R, Minnion J, Tan T, Bloom SR. Scott R, et al. Peptides. 2018 Jun;104:70-77. doi: 10.1016/j.peptides.2018.04.008. Epub 2018 Apr 20. Peptides. 2018. PMID: 29680267 Free PMC article.

4

Of Mice Not Men? Actions of Interleukin-6 on Glucose Tolerance.

McGlone ER, Tan TM. McGlone ER, et al. Among authors: tan tm. Cell Metab. 2018 Jun 5;27(6):1157-1158. doi: 10.1016/j.cmet.2018.05.013. Cell Metab. 2018. PMID: 29874560 Free article.

5

What Can We Learn From Mouse Models About Bile Acid-Mediated Changes After Bariatric Surgery?

McGlone ER, Tan T, Bloom SR, Walters JRF. McGlone ER, et al. Gastroenterology. 2019 Jul;157(1):4-8. doi: 10.1053/j.gastro.2019.02.048. Epub 2019 Mar 28. Gastroenterology. 2019. PMID: 30930023 Free article. No abstract available.

6

Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial.

Miras AD, Pérez-Pevida B, Aldhwayan M, Kamocka A, McGlone ER, Al-Najim W, Chahal H, Batterham RL, McGowan B, Khan O, Greener V, Ahmed AR, Petrie A, Scholtz S, Bloom SR, Tan TM. Miras AD, et al. Among authors: tan tm. Lancet Diabetes Endocrinol. 2019 Jul;7(7):549-559. doi: 10.1016/S2213-8587(19)30157-3. Epub 2019 Jun 4. Lancet Diabetes Endocrinol. 2019. PMID: 31174993 Clinical Trial.

7

Candy cane revision after Roux-en-Y gastric bypass.

Kamocka A, McGlone ER, Pérez-Pevida B, Moorthy K, Hakky S, Tsironis C, Chahal H, Miras AD, Tan T, Purkayastha S, Ahmed AR. Kamocka A, et al. Surg Endosc. 2020 May;34(5):2076-2081. doi: 10.1007/s00464-019-06988-4. Epub 2019 Aug 8. Surg Endosc. 2020. PMID: 31392513 Free PMC article.

8

Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors.

Jones B, McGlone ER, Fang Z, Pickford P, Corrêa IR Jr, Oishi A, Jockers R, Inoue A, Kumar S, Görlitz F, Dunsby C, French PMW, Rutter GA, Tan T, Tomas A, Bloom SR. Jones B, et al. J Biol Chem. 2021 Jan-Jun;296:100133. doi: 10.1074/jbc.RA120.016334. Epub 2020 Dec 4. J Biol Chem. 2021. PMID: 33268378 Free PMC article.

9

Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist.

Pickford P, Lucey M, Rujan RM, McGlone ER, Bitsi S, Ashford FB, Corrêa IR, Hodson DJ, Tomas A, Deganutti G, Reynolds CA, Owen BM, Tan TM, Minnion J, Jones B, Bloom SR. Pickford P, et al. Among authors: tan tm. Mol Metab. 2021 Sep;51:101242. doi: 10.1016/j.molmet.2021.101242. Epub 2021 Apr 30. Mol Metab. 2021. PMID: 33933675 Free PMC article.

10

Receptor Activity-Modifying Protein 2 (RAMP2) alters glucagon receptor trafficking in hepatocytes with functional effects on receptor signalling.

McGlone ER, Manchanda Y, Jones B, Pickford P, Inoue A, Carling D, Bloom SR, Tan T, Tomas A. McGlone ER, et al. Mol Metab. 2021 Nov;53:101296. doi: 10.1016/j.molmet.2021.101296. Epub 2021 Jul 13. Mol Metab. 2021. PMID: 34271220 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page